Evidence-Based Medicine Guidelines
Dopamine agonists for the treatment of restless legs syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dopamine Agonists for the Treatment of Restless Legs Syndrome." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450227/all/Dopamine_agonists_for_the_treatment_of_restless_legs_syndrome.
Dopamine agonists for the treatment of restless legs syndrome. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/450227/all/Dopamine_agonists_for_the_treatment_of_restless_legs_syndrome. Accessed October 14, 2024.
Dopamine agonists for the treatment of restless legs syndrome. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/450227/all/Dopamine_agonists_for_the_treatment_of_restless_legs_syndrome
Dopamine Agonists for the Treatment of Restless Legs Syndrome [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450227/all/Dopamine_agonists_for_the_treatment_of_restless_legs_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dopamine agonists for the treatment of restless legs syndrome
ID - 450227
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450227/all/Dopamine_agonists_for_the_treatment_of_restless_legs_syndrome
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
